Vivos Sistema de Cirurgia Oftálmica por Olcayto Guelec and David Geuder

O design Vivos Sistema de Cirurgia Oftálmica por Olcayto Guelec and David Geuder é um vencedor altamente estimado do prestigioso 2026 A' Design Award de Ouro na Categoria de Competição Design de Dispositivos e Equipamentos Médicos.

OuroProduto Médico· 2026

Vivos Sistema de Cirurgia Oftálmica

por Olcayto Guelec and David Geuder

Cliente: Geuder AG

Vencedor do A' Design Award de Ouro na Categoria Produto Médico

56,783

Vencedor de Prémio Verificado

Verificar Estado do Prémio para #182492

Ver no A' Design Award Comunicado de Imprensa Selo do Prémio

Cores

O Design

Sobre Vivos Sistema de Cirurgia Oftálmica

O Vivos redefine a estação de trabalho cirúrgica como uma plataforma que evolui a par da ambição clínica. Três configurações, Core, Nova e Nova+, ampliam a capacidade sem substituição do sistema, a única arquitetura de atualização do seu género na cirurgia oftálmica. Uma única interface, validada com 91,7 por cento de satisfação na primeira utilização sem formação prévia, reflete um design concebido em torno do cirurgião e não do procedimento. As conexões iluminadas dos instrumentos, os materiais refinados e o detalhe contido conferem ao dispositivo uma presença serena e confiante, livre do ruído visual típico da categoria.

O Reconhecimento

Sobre o A' Design Award de Ouro

Vivos Sistema de Cirurgia Oftálmica conquistou o A' Design Award de Ouro, um reconhecimento imensamente prestigiado atribuído a designs de primeira linha, maravilhosos e notáveis. Os vencedores do Ouro são criações extremamente inovadoras, visionárias e glamorosamente deslumbrantes, que refletem o prodígio, a sabedoria e a proeza dos seus designers. Espera-se que Vivos Sistema de Cirurgia Oftálmica seja uma invenção muito elogiada, pioneira e monumental, que oferece um valor sem precedentes. Este design vencedor do A' Design Award de Ouro é um projeto espetacular e respeitado, que beneficia muito e faz avançar as fronteiras da arte, da ciência, do design e da tecnologia. Vivos Sistema de Cirurgia Oftálmica cria sentimentos intensos de desejo, evoca paixão, incentiva a criatividade e fascina-nos.

Por Trás do Design

Kit de Imprensa

Créditos, membros da equipa e detalhes técnicos fornecidos pelo designer.

Propriedades Únicas: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensões e Embalagem: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Etiquetas: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Tecnologia de Produção: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Desafio de Design: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Pesquisa: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiração: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Duração do Projeto: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Fluxo de Operação: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Membros da Equipa: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Créditos de Imagem: Photography Geuder AG, 2026